China detains suspects after blast at chemical plant

This photo taken on July 12, 2018 shows firefighters working to put out a fire after an explosion at a chemical plant in Yibin in China's southwestern Sichuan province. (AFP)
Updated 14 July 2018

China detains suspects after blast at chemical plant

  • In 2015, giant chemical blasts in a container storage facility killed at least 165 people in the northern port city of Tianjin
  • China has been rocked by several industrial accidents in recent years

BEIJING: Authorities have detained “several” suspects in wake of an explosion at a chemical plant in southwest China that left 19 dead and injured 12 others, state media said.
The blast occurred at 6:30 p.m. (1030 GMT) Thursday at an industrial park in Sichuan province’s Yibin city, according to a statement on the website of the local work safety administration.
Photos on a local news website showed what appeared to be the burned out shell of a building surrounded by rubble.
The building was owned by chemical manufacturer Hengda, which was “conducting illegal construction at the plant which had not passed safety and fire control checks,” the official Xinhua news agency said late Friday, citing local authorities.
The Ministry of Emergency Management has sent a team to further investigate the cause of the explosion, the agency added.
China has been rocked by several industrial accidents in recent years.
A septic tank explosion last November destroyed a wide swathe of a light industrial area in Ningbo, just south of Shanghai.
In 2015, giant chemical blasts in a container storage facility killed at least 165 people in the northern port city of Tianjin.
The explosions caused more than $1 billion in damage and sparked widespread anger at a perceived lack of transparency over the accident’s causes and its environmental impact.
A government inquiry eventually recommended 123 people be punished. Tianjin’s mayor at the time of the accident was sentenced to 12 years in prison for graft in September.


UK testing ibuprofen as coronavirus treatment

Updated 04 June 2020

UK testing ibuprofen as coronavirus treatment

  • Anti-inflammatory properties of the drug could treat breathing difficulties

LONDON: Scientists in London are running a drugs trial to test if ibuprofen is an effective treatment for hospital patients with COVID-19.

The teams at Guy’s and St. Thomas’s hospital and researchers from King’s College London believe that the anti-inflammatory properties of the drug could treat breathing difficulties.

Struggling with breathing, and the demand on ventilators in intensive care units, have been two major challenges regarding COVID-19. Researchers hope that the low-cost painkiller could reduce the reliance on ventilators.

The trial, called Liberate, will treat half the patients with ibuprofen on top of their usual care. The researchers will use a special formulation of ibuprofen that some people already take for arthritis.

Previous studies in animals have shown that it might treat acute respiratory distress syndrome, which is one of the complications caused by severe COVID-19 infections.

Prof. Mitul Mehta from the King’s College London team said: “We need to do a trial to show that the evidence actually matches what we expect to happen.”

At the onset of the pandemic, there were concerns that ibuprofen would aggravate the infection, with French Health Minister Oliver Veran advising patients to take paracetamol instead.